Tim Diederichs1, Robert Tampé1. 1. Institute of Biochemistry, Biocenter, Goethe-University Frankfurt, Max-von Laue-Straße 9, 60438 Frankfurt a.M., Germany.
Abstract
Cellular life depends on transport and communication across membranes, which is emphasized by the fact that membrane proteins are prime drug targets. The cell-like environment of membrane proteins has gained increasing attention based on its important role in function and regulation. As a versatile scaffold for bottom-up synthetic biology and nanoscience, giant liposomes represent minimalistic models of living cells. Nevertheless, the incorporation of fragile multiprotein membrane complexes still remains a major challenge. Here, we report on an approach for the functional reconstitution of membrane assemblies exemplified by human and bacterial ATP-binding cassette (ABC) transporters. We reveal that these nanomachineries transport substrates unidirectionally against a steep concentration gradient. Active substrate transport can be spatiotemporally resolved in single cell-like compartments by light, enabling real-time tracking of substrate export and import in individual liposomes. This approach will help to construct delicate artificial cell-like systems.
Cellular life depends on transport and communication across membranes, which is emphasized by the fact that membrane proteins are prime drug targets. The cell-like environment of membrane proteins has gained increasing attention based on its important role in function and regulation. As a versatile scaffold for bottom-up synthetic biology and nanoscience, giant liposomes represent minimalistic models of living cells. Nevertheless, the incorporation of fragile multiprotein membrane complexes still remains a major challenge. Here, we report on an approach for the functional reconstitution of membrane assemblies exemplified by human and bacterial ATP-binding cassette (ABC) transporters. We reveal that these nanomachineries transport substrates unidirectionally against a steep concentration gradient. Active substrate transport can be spatiotemporally resolved in single cell-like compartments by light, enabling real-time tracking of substrate export and import in individual liposomes. This approach will help to construct delicate artificial cell-like systems.
ABC transporters represent one of the largest and probably most ancient protein
superfamilies, shuttling a broad range of chemically distinct compounds across lipid
bilayers.[1−3] These machines share a
common blueprint of two nucleotide-binding domains (NBDs) operating in concert with two
transmembrane domains (TMDs).[4,5] ATP binding and NBD dimerization switch the transporter from an
inward-facing to an outward-facing state.[6,7] Substrate translocation across membranes is assisted by
large conformational changes before ATP hydrolysis, and phosphate release changes the
transporter back to the inward-facing state.[8,9] Owing to their versatile cellular function, ABC transporters
are linked to many diseases. For example, the transporter associated with antigen processing
(TAP1/2) plays a vital role in adaptive immunity.[6,10] The heterodimeric ABC transporter TmrAB from
Thermus thermophilus exhibits structural and functional homology with TAP
and can restore antigen processing in TAP-deficient human cells.[11] The
related ABC transporter TAP-like (TAPL) consists of a core transporter (coreTAPL) and an
extra membrane-embedded TMD0 domain, responsible for lysosomal
targeting.[12−14] The homodimeric complex
transports polypeptides into lysosomes and has been linked to lysosome
biogenesis.[15,16]Giant liposomes have gained increasing attention as minimalistic model systems, which mimic
the size and shape of cells, making them ideal targets for light microscopy and studies of
membrane morphology.[17−19] The reduced membrane
tension and curvature can affect the properties of membrane proteins.[20]
Nevertheless, the functional reconstitution of fragile membrane proteins in giant
unilamellar vesicles (GUVs) remains a major bottleneck because preparation methods such as
electroformation[21] or hydrogel-assisted swelling[22,23] harm protein integrity by drying of
proteoliposomes upon reconstitution.[24] Inkjetting,[25,26] vesicle fusion,[27−30] or detergent-mediated
reconstitution[31,32]
comprise the drawback of requiring specialized equipment, delicate handling, and specific
fusogenic proteins or lipids, which limits their broader application. To date, only a few
examples of ATP-dependent transporters reconstituted in giant liposomes are
known.[31,33−36] Large concentrative substrate translocation,
which is a hallmark of primary active transporters, has not yet been
demonstrated.[33−36]Here, we established a versatile approach for the functional reconstitution of membrane
protein complexes in giant liposomes via hydrogel-assisted swelling using
poly(vinyl alcohol) (PVA) by carefully optimizing conditions for protein activity. As a
proof of principle, human and bacterial ABC transporters were functionally reconstituted.
Our proteoGUV preparation amalgamates three steps: (i) reconstitution in large unilamellar
vesicles (LUVs), (ii) meticulous drying of proteoliposomes with additional sucrose on a PVA
hydrogel in a fine-tuned humid environment, and (iii) giant liposome formation by
rehydration in physiological buffer supplemented with sucrose. The detergent-mediated
reconstitution was used to incorporate both peptide transporters in large
liposomes.[37,38]
Results and Discussion
We first examined the reconstitution of TmrAB by direct and indirect fluorescence labeling.
SulfoCy5-labeled TmrAB colocalizes with the lipid membrane after proteoGUV formation,
indicating membrane incorporation (Figure a).
Alternatively, TmrAB was site-specifically labeled by
trisNTAAlexa647via a C-terminal His-tag,[9,39−41] confirming that a fraction of the transporters is facing the NBDs to the
external medium (Figure b, upper panel). In
contrast, liposomes lacking TmrAB did not show trisNTAAlexa647
labeling (Figure b, lower panel). To address the
function of the transport complex, we determined the ATP activity of TmrAB after
reconstitution into GUVs. ProteoGUVs were generated, detached, and separated from the PVA
hydrogel, followed by solubilization with a mild nonionic detergent. A high ATPase activity
above background demonstrated TmrAB function (Figure c).
Figure 1
Reconstitution of ABC transporters in giant liposomes. (a) SulfoCy5-labeled TmrAB was
reconstituted in GUVs at a protein-to-lipid ratio of 1:20w/w. A line profile
displays the mean gray values (mgv). (b) GUVs with and without reconstituted TmrAB were
site-specifically labeled via the C-terminal His-tag of TmrA by
trisNTAAlexa647. For dual-color visualization, the
fluorescence gain was enhanced in the lower left and right image. The lipid bilayer was
stained by DOPEATTO390. Line profiles demonstrate the colocalization of TmrAB
and the lipid bilayer. (c) ATPase activity of TmrAB in isolated GUVs after detergent
solubilization. The mean ± SD (n = 3) is shown.
Reconstitution of ABC transporters in giant liposomes. (a) SulfoCy5-labeled TmrAB was
reconstituted in GUVs at a protein-to-lipid ratio of 1:20w/w. A line profile
displays the mean gray values (mgv). (b) GUVs with and without reconstituted TmrAB were
site-specifically labeled via the C-terminal His-tag of TmrA by
trisNTAAlexa647. For dual-color visualization, the
fluorescence gain was enhanced in the lower left and right image. The lipid bilayer was
stained by DOPEATTO390. Line profiles demonstrate the colocalization of TmrAB
and the lipid bilayer. (c) ATPase activity of TmrAB in isolated GUVs after detergent
solubilization. The mean ± SD (n = 3) is shown.ABC transporters are often assessed by their ATPase activity; however, the most important
property is substrate translocation against a concentration gradient. We reconstituted
fluorescently tagged human core TAPL, termed coreTAPLmVenus, in giant liposomes.
Colocalization of mVenus fluorescence and the lipid membrane indicated incorporation of the
complex (Figure a). TAPL function was assessed by
translocation of the fluorescein-labeled peptide C4F in the presence of an ATP-regeneration
system (ARS). Using confocal microscopy, we followed peptide accumulation above background,
reaching a 4-fold increase at 37 °C (n = 11, number of imaged
TAPL-containing GUVs). The membrane integrity was confirmed and no passive diffusion of C4F
was observed in the absence of ATP (Figure S1).
Figure 2
Functional reconstitution and active uphill transport of human TAPL in giant liposomes.
(a) CoreTAPLmVenus incorporation and ATTO655 encapsulation in
giant liposomes. (b) Peptide transport of coreTAPLmVenus for 2 h at 37
°C, after addition of ATP, ARS, and C4F peptides. Scale bars, 10 μm. All
images are processed by ImageJ for better visualization.
Functional reconstitution and active uphill transport of human TAPL in giant liposomes.
(a) CoreTAPLmVenus incorporation and ATTO655 encapsulation in
giant liposomes. (b) Peptide transport of coreTAPLmVenus for 2 h at 37
°C, after addition of ATP, ARS, and C4F peptides. Scale bars, 10 μm. All
images are processed by ImageJ for better visualization.Owing to the short functional lifetime of TAPL, which hinders long-term transport
assays,[12] we focused on the bacterial ABC transporter TmrAB. To track
single-liposome transport over extended periods of time, we tethered biotinylated proteoGUVs
via streptavidin to biotin-functionalized PEG glass slides (Figure a). Based on the thermophilic nature of TmrAB,
all the following experiments were performed at 40 °C with an ARS and a
protein-to-lipid reconstitution ratio of 1:15w/w. Under these conditions, the
membrane integrity and leakage were monitored by Oyster647, a small,
membrane-impermeable fluorophore (Figure b). After
addition of ATP and C4F peptide, substrate accumulation in giant liposomes was monitored in
real time. It is worth mentioning that the background fluorescence of C4F is lower at the
beginning of the time-lapse recordings due to incomplete diffusion in the reservoir chamber.
Notably, individual giant liposomes showed a >120-fold accumulation compared to
background fluorescence, demonstrating active transport against a steep concentration
gradient (Figure c). Before initiating the
transport reaction by ATP addition, proteoGUVs show lower fluorescence in the interior
compared to background (Figure S2). Building up high concentration gradients is a hallmark of
primary-active transporters and has not been achieved in giant liposomes so far. Limitations
in even higher accumulation capacities are most likely caused by ATP depletion and product
(ADP) inhibition because protein stability for more than 2 h has been confirmed by transport
studies with preincubated TmrAB at 40 °C (Figure S3). A 4000-fold accumulation in large unilamellar liposomes
(∼100 nm) was previously observed, which requires high concentrations of
phosphocreatine and ATP (24 and 3 mM, respectively).[11] These conditions
are incompatible with giant vesicle stabilities. The critical membrane tension resulting in
membrane rupture is about 10 mN/m for
1,2-dioleyl-sn-glycero-3-phosphocholine (DOPC) membranes,[42] which corresponds to a concentration gradient of a few millimolar.[43]
Figure 3
Transport against a concentration gradient. (a) Transport assay of TmrAB in giant
liposomes. The membrane-impermeable Oyster647 dye was encapsulated in
proteoGUVs to control membrane integrity. GUVs were tethered to functionalized glass
slides. ATP was added to drive the transport of fluorescent C4F peptides. (b) Time-lapse
recordings demonstrate the transport activity of TmrAB. GUVs were filled with the
Oyster647 fluorophore, and transport was induced by addition of ATP, ARS,
and C4F peptides. Scale bar, 10 μm. (c) Representative analysis of two time-lapse
traces. The accumulation of C4F peptides in giant liposomes was normalized to background
fluorescence. (d) Rate constants (C4F per TmrAB per min) were determined for different
C4F concentrations. Each dot represents the transport rate for an individual giant
liposome. The median is given for each box plot (red line) and is illustrated in the
inset for various peptide concentrations; 25–75% of the mean are shown as boxes
and error bars as SD. The data were obtained from more than nine independent experiments
(biological replicates).
Transport against a concentration gradient. (a) Transport assay of TmrAB in giant
liposomes. The membrane-impermeable Oyster647 dye was encapsulated in
proteoGUVs to control membrane integrity. GUVs were tethered to functionalized glass
slides. ATP was added to drive the transport of fluorescent C4F peptides. (b) Time-lapse
recordings demonstrate the transport activity of TmrAB. GUVs were filled with the
Oyster647 fluorophore, and transport was induced by addition of ATP, ARS,
and C4F peptides. Scale bar, 10 μm. (c) Representative analysis of two time-lapse
traces. The accumulation of C4F peptides in giant liposomes was normalized to background
fluorescence. (d) Rate constants (C4F per TmrAB per min) were determined for different
C4F concentrations. Each dot represents the transport rate for an individual giant
liposome. The median is given for each box plot (red line) and is illustrated in the
inset for various peptide concentrations; 25–75% of the mean are shown as boxes
and error bars as SD. The data were obtained from more than nine independent experiments
(biological replicates).It is worth noting that the volume of liposomes scales with the radius to the power of 3,
while the surface area (proportional to the number of reconstituted transporters) scales to
the power of 2. This scaling difference between surface and volume restricts the
accumulation in giant liposomes for a given period of time compared to ∼100 nm
vesicles. For example, for liposomes of 0.1 and 10.9 μm in diameter, 0.02 ×
10–3 and 1.84 × 10–3 fL per transporter have to
be filled, respectively (compare Table ). In order
to achieve a similar accumulation, a substantially larger volume must be filled with
substrates per transporter. Passive diffusion, which could account for reduced accumulation,
is negligible due to the high membrane integrity monitored by the control dye
Oyster647. Table resumes a
calculation to compare the properties between large and giant liposomes.
Table 1
Comparison of Transport Properties in Large and Giant Proteoliposomes
diameter (μm)
surface (μm2)
volume (μm3)
TmrAB/vesicle
transport rate (1/min)
LUVs
∼0.1a
0.06a
0.5 × 10–3a
25a
GUVs
10.9b
820b
920b
∼0.5 × 106
0.31b
GUVs
19.0c
2600c
5200c
∼1.5 × 106c
0.50c
Derived from ref. (11) for proteoliposomes
incubated in 10 μM C4F at 68 °C.
Parameters are means obtained from 19 individual single GUVs for the addition of 1
μM C4F.
Parameters are means obtained from 17 individual single GUVs for 3 μM C4F. Rate
constants of GUVs are given as medians.
Derived from ref. (11) for proteoliposomes
incubated in 10 μM C4F at 68 °C.Parameters are means obtained from 19 individual single GUVs for the addition of 1
μM C4F.Parameters are means obtained from 17 individual single GUVs for 3 μM C4F. Rate
constants of GUVs are given as medians.We examined the transport rates (C4F peptides per TmrAB per min) for different peptide
concentrations (Figure d). Each dot represents the
rate constant for an individual giant liposome. The median for the rate constant at
different peptide concentrations is given as a red line, as it is less dependent on
outliers. The transport rates increase with rising peptide concentration (Figure d, inset). We derived a Km
value of 1.8 ± 1.0 μM and a turnover of TmrAB of approximately one peptide per
minute at 40 °C. For TmrAB reconstituted in large liposomes, a
Km,C4F of 8.3 μM and turnover of four peptides per TmrAB
and minute were determined at 68 °C,[11] which indicates a similar
transporter activity considering the temperature dependence of the transport.[44]We next examined whether the transport activity and directionality in individual liposomes
can be controlled by light. Photocaged-ATP, ARS, Oyster647, and C4F peptides were
encapsulated in the lumen of proteoGUVs (Figure a). Caged-ATP is a nonhydrolyzable nucleotide triphosphate analogue with a
P3-(1-(4,5-dimethoxy-2-nitrophenyl)ethyl (DMNPE)-caged
γ-phosphate, which can be cleaved by illumination at 405 nm using confocal
scanning-laser microscopy. Before photoactivation, Oyster647 fluorophores and C4F
peptides are stably encapsulated in the giant liposomes without membrane leakage (Figure S4).
Figure 4
Light-controlled unidirectional export and sequential import. (a) Light-controlled
export of TmrAB in giant liposomes. Caged-ATP was activated in situ by
illumination at 405 nm using a confocal laser-scanning microscope. (b) Time-lapse images
of the light-controlled export assay. Scale bar, 10 μm. (c) Time-dependent change
in fluorescence intensity of C4F peptide. The inset illustrates the fluorescence signal
of an exemplary GUV loaded with caged-ATP before photoactivation. (d) Export efflux
constants for nine individual GUVs were summarized in a histogram. (e) Export and import
of C4F peptides for the same giant liposome. The experiment was performed under
identical conditions to those in (a), followed by addition of ATP and ARS driving
peptide import. The focus was readjusted after addition of ATP/ARS, and the brightness
of the red channel was enhanced by 6% for better visualization. Normalized and
background-corrected fluorescence intensities (%) for the dyes inside the GUVs’
lumen are given below the images. Scale bar, 10 μm.
Light-controlled unidirectional export and sequential import. (a) Light-controlled
export of TmrAB in giant liposomes. Caged-ATP was activated in situ by
illumination at 405 nm using a confocal laser-scanning microscope. (b) Time-lapse images
of the light-controlled export assay. Scale bar, 10 μm. (c) Time-dependent change
in fluorescence intensity of C4F peptide. The inset illustrates the fluorescence signal
of an exemplary GUV loaded with caged-ATP before photoactivation. (d) Export efflux
constants for nine individual GUVs were summarized in a histogram. (e) Export and import
of C4F peptides for the same giant liposome. The experiment was performed under
identical conditions to those in (a), followed by addition of ATP and ARS driving
peptide import. The focus was readjusted after addition of ATP/ARS, and the brightness
of the red channel was enhanced by 6% for better visualization. Normalized and
background-corrected fluorescence intensities (%) for the dyes inside the GUVs’
lumen are given below the images. Scale bar, 10 μm.After illumination and confined ATP generation in the lumen of the GUV, we observed peptide
export, reflected by a monoexponential decay of the C4F signal (Figure
b). In contrast, the fluorescence of the membrane-impermeable
Oyster647 dye, which is not transported by TmrAB, remains stable. A
representative single-liposome export trace is shown in Figure c. Active transport exceeded the concentration equilibrium by
exporting below the background concentration, additionally confirming active transport
processes (Figure c). It is worth mentioning that
only minimal fluorescence bleaching of C4F was observed without activation of caged-ATP
(Figure c, inset). Liposomes of different
diameters were photoactivated, and the export traces were monoexponentially fitted. The
resulting rate constants are summarized in a histogram (Figure d). The majority of the proteoGUVs show export traces in the range of
0.05–0.1/min. This indicates that approximately 3 to 4 peptides are transported per
TmrAB per minute (mean value), assuming a random (50:50) TmrAB orientation. Further
information on the calculation is given in the Experimental Section.
In very rare cases, an efflux of both C4F and Oyster647 was observed after
in situ photoactivation, indicating membrane leakiness (Figure S5).To compare export and import processes in individual giant liposomes, caged-ATP, ARS,
Oyster647, and C4F peptides were encapsulated in their lumen. In
situ photoactivation of an individual GUV results in export of C4F peptides,
which can be reversed after addition of ATP and ARS to the external medium (Figure e). Photoinduced export followed by ATP-triggered import
of an individual liposome in the vicinity of a cluster of vesicles additionally confirms the
spatiotemporal specificity (Figure S6). Thereby, active export can be compared to active import in a
single giant liposome, demonstrating the transport directionality and random orientation of
TmrAB in giant liposomes.
Conclusion
In summary, we present a versatile approach for the functional reconstitution of membrane
transport machineries in giant liposomes, exemplified by the bacterial ABC transport complex
TmrAB and the human lysosomal exporter TAPL. Unidirectional transport against a steep
gradient reveals activities for TmrAB peaking in a >120-fold accumulation in the lumen of
the GUVs, with transport rates comparable to those of large unilamellar vesicles.[11] These high accumulations are a hallmark of active transporters such as
OpuA[45,46] and have
not been achieved in giant liposomes so far. Furthermore, active transport was controlled in
time and in space by light, which enabled export and import processes on individual giant
vesicles. Giant liposomes are activated in situ to follow active
unidirectional export and import by nanomachineries in real time.
Experimental Section
Materials
All chemicals were purchased from Sigma-Aldrich, Carl Roth GmbH + Co. KG, or VWR
International GmbH unless stated otherwise.
Expression and Purification TmrAB
Expression and purification of TmrAB were performed as previously
described.[11,47] In
short, TmrAB was produced in Escherichia coli BL21(DE3) grown in LB
high-salt media at 37 °C, with 180 rpm shaking and induced by 0.5 mM isopropyl
β-d-1-thiagalactopyranoside (IPTG). All following steps were performed at
4 °C. Cells were harvested and resuspended in lysis buffer (20 mM HEPES/NaOH pH 7.5,
300 mM NaCl, 50 μg/mL lysozyme, 0.2 mM phenylmethylsulfonyl fluoride (PMSF)),
followed by sonification and low-speed centrifugation at 10000g for 15
min to pellet cell debris. TmrAB was extracted from crude membranes by solubilization with
1%w/v β-n-dodecyl β-d-maltoside
(β-DDM) in purification buffer (20 mM HEPES/NaOH pH 7.5, 300 mM NaCl, 0.2 mM PMSF)
followed by centrifugation at 115000g for 30 min. Ni-NTA agarose beads
(Qiagen) supplemented with 30 mM imidazole were used to bind the C-terminal
His10-tagged TmrAB for 60 min and applied to a gravity flow column. Beads
were washed with 20 column volumes (20 mM HEPES/NaOH pH 7.5, 300 mM NaCl,
0.05%w/v β-DDM, 50 mM imidazole), followed by elution (20 mM HEPES/NaOH
pH 7.5, 300 mM NaCl, 0.05%w/v β-DDM, 300 mM imidazole). Fractions
containing TmrAB were pooled and stored at 4 °C after buffer exchange (20 mM
HEPES/NaOH pH 7.5, 150 mM NaCl, 0.05%w/v β-DDM). The concentration was
determined by absorbance of 280 nm (ε280nm = 159 630
cm–1 M–1, Mw =
134 900 Da). Purity of TmrAB was analyzed by SDS-PAGE (10%), followed by Coomassie
staining (InstantBlue; Expedeon) (SI Figure S7).
Expression and Purification of CoreTAPLmVenus
Expression and purification of coreTAPLmVenus were performed as
described.[48] In brief, coreTAPLmVenus was expressed in
Pichia pastoris in a Labfors4 benchtop bioreactor (Infors HT). All
following steps were performed at 4 °C. Cells (1/3 volume) were harvested and mixed
with 1/3 volume of breaking buffer (50 mM KH2PO4 pH 7.5, 1 mM EDTA,
5 mM aminocaproic acid, 5%v/v glycerol) and 1/3 volume of washed glass beads.
Cells were disrupted by shaking in a FastPrep-24 system (MP Biomedicals) for 45 s at 5 m/s
for five cycles with 2 min cooling steps in between. Membranes were collected by
centrifugation at 3500g for 15 min. Subsequently, crude membranes were
extracted at 100000g for 45 min and resuspended in HEPES buffer (20 mM
HEPES/NaOH pH 7.5, 500 mM NaCl, 2 mM benzamidine, 1 mM PMSF, 15%v/v glycerol)
followed by Dounce homogenization. Crude membranes were solubilized (5 mg/mL total
proteins) for 2 h in HEPES buffer containing 1%w/v β-DDM and 20 mM
imidazole. Excess membranes were centrifuged by 100000g for 45 min, and
the supernatant was incubated with Ni-NTA agarose beads for 3 h in an overhead rotor.
Ni-NTA beads were loaded on a gravity flow column and washed with 20 column volumes (20 mM
HEPES/NaOH pH 7.5, 500 mM NaCl, 2 mM benzamidine, 1 mM PMSF, 100 mM imidazole,
15%v/v glycerol, and 0.05%w/v β-DDM).
CoreTAPLmVenus was eluted with HEPES buffer supplemented with 300 mM
imidazole and 0.05%w/v β-DDM. Fractions containing
coreTAPLmVenus were pooled and stored after buffer exchange (20 mM HEPES/NaOH
pH 7.5, 150 mM NaCl, 0.05%w/v β-DDM, 5%v/v glycerol) at 4
°C. CoreTAPLmVenus concentration was determined by specific absorbance of
mVenus (ε515 nm = 45 950 cm–1
M–1). Purity was analyzed by SDS-PAGE (10%) and Coomassie staining
(InstantBlue; Expedeon), as well as by in-gel fluorescence of mVenus
(λex/em = 480/520 nm) (Figure S8).
Peptide Labeling and Purification
The 9-mer peptide RRYCKSTEL was synthesized by solid-phase synthesis followed by
fluorescein labeling. The peptide was dissolved in PBS (10 mM
Na2HPO4, 2 mM KH2PO4, 137 mM NaCl, 2.7 mM
KCl, pH 6.5) supplemented with 3.5 mM dimethylformamide (DMF) and incubated for 1 h at RT
with 1.2 molar excess of 5-iodoacetamidofluorescein (Merck) dissolved in DMF. Labeled
peptides were purified by reverse-phase C18-HPLC (PerfectSil 300 ODS C18, 5
μm, 250 × 10 mm; MZ Analysentechnik) using a linear gradient from 5% to
100%v/v acetonitrile supplemented with 0.1%v/v trifluoroacetic
acid. The identity of the peptides was verified by mass spectroscopy. Concentration was
determined by absorption (ε492 nm = 75 000
cm–1 M–1, pH 9.0).
Fluorescently Labeled TmrAB
The single natural cysteine in wild-type TmrAB at position 416 in TmrA was labeled by
maleimide chemistry. Therefore, TmrAB was incubated with sulfoCy5 maleimide (Lumiprobe) in
PBS pH 6.8 for 1 h at room temperature. A protein concentration of 1 mg/mL and 20-fold
molar excess of sulfoCy5 maleimide were used. Subsequently, the reaction was quenched with
1 mM β-mercaptoethanol. Dye excess was removed via size-exclusion
spin columns (Bio-Rad) followed by size-exclusion chromatography (SEC).
Liposome Preparation
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC),
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG),
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE),
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(Cap
biotinyl) (biotinylated-DOPE), E. coli polar lipids, and
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) were purchased from
Avanti Polar Lipids Inc., and
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine coupled to
ATTO390 (DOPEATTO390) was purchased from ATTO-TEC GmbH.
POPC/POPG/POPE/biotinylated-DOPE (40:30:29:1 mol%), POPC/POPG/POPE/DOPEATTO390
(40:30:29.5:0.5 mol%), and E. coli polar lipids/DOPC (70:30 mol%) were
mixed in chloroform to a concentration of 5 mg/mL, dried by a rotary evaporator, and
subsequently resolved in 20 mM HEPES/NaOH pH 7.5, 150 mM NaCl. Large unilamellar vesicle
formation was conducted as described including sonication and freeze–thaw
cycles.[49,50]
Functional Reconstitution in Large Unilamellar Vesicles
TmrAB or coreTAPLmVenus were reconstituted in liposomes of
POPC/POPG/POPE/biotinylated-DOPE (40:30:29:1 mol%) or E. coli polar
lipids/DOPC (70:30 mol%) with protein-to-lipid ratios of 1:15w/w and
1:40w/w, respectively.[9,51] Liposomes were extruded 11 times through 100 nm polycarbonate
membranes, and all flowing steps were performed at 4 °C. Liposomes were destabilized
by the addition of Triton X-100 4%v/v for 30 min, followed by incubation with
the membrane protein complexes for 30 min on an overhead shaker. Detergent was gradually
removed by four times addition of polystyrene beads (Bio-Beads SM-2, Bio-Rad). The first
two additions of 40 mg/mL were incubated for 1 h and overnight, followed by two additions
of 80 mg/mL each for 2 h. Proteoliposomes were harvested by centrifugation for 45 min at
300000g and resuspended in the appropriate buffer.
Formation of ProteoGUVs
Giant proteoliposomes were produced by hydrogel-assisted swelling of dried
proteoliposomes.[23] Therefore, 5%w/w solution of PVA (Merck
KGaA) was dissolved in water and heated to 95 °C, followed by cooling to 38 °C.
Afterward, 200 μL of the PVA solution was spread over a cover slide and dried at 50
°C for 30 min. Preformed proteoliposomes (5 mg/mL) were supplemented with sucrose
(0.2 g sucrose/g lipid) and distributed in very small droplets on the dried PVA slide, to
ensure fast drying. The PVA slide was placed under vacuum for at least 10 min in a
humidity environment generated by NaCl. After drying, the PVA slide was rehydrated by the
appropriate buffer containing 200 mM sucrose and incubated for 30 min before harvesting of
proteoGUVs. Desired compounds for encapsulation must be included in the swelling buffer.
The drying time drastically influences the protein activity and liposome yield. Here, we
optimized the protocol for protein activity at the expense of GUV yield.
Oyster647 and ATTO655 were purchased from Bio-Synthesis Inc. and
ATTO-TEC GmbH, respectively. The sizes of the proteoGUVs were analyzed individually
(n = 56, Figure S9).
ATPase Assay
The ATPase activity of DDM-solubilized proteoGUVs containing TmrAB was determined by
using a Malachite Green-based colorimetric assay.[52]
Detergent-solubilized TmrAB (0.5 μM) was incubated in ATPase buffer (20 mM
HEPES/NaOH pH 7.5, 150 mM NaCl, 2 mM MgCl2, 0.2%w/v β-DDM) in
the presence of 2 mM Mg-ATP at 40 °C for 8 min and H2O as control.
Transport was stopped by the addition of 20 mM H2SO4 supplemented
with Malachite Green solution (3 mM Malachit Green, 0.2%v/v Tween 20,
1.5%w/v ammonium molybdate), and the absorbance of 620 nm was detected after
10 min of incubation at RT using the ELISA reader (CLARIOstar, BMG LABTECH).
Functionalized Glass Slides
Glass slides (170 ± 10 μm) were cleaned by oxygen plasma at 0.3 mbar and 80%
power for 15 min (Diener Electronics), followed by silanization with
(3-aminopropyl)triethoxysilane (APTES) as described.[53] The amino group
is coupled via an N-hydroxysuccinimide ester to
biotinylated-PEG/PEG (1:10w/w, Rapp Polymere GmbH) followed by extensive
washing with Milli Q water (Merck KGaA). Functionalized surfaces were covered by argon and
stored at −20 °C. Sticky-slides (ibidi) were used for all transport
experiments, and a lid was used to prevent evaporation.
Peptide Translocation into Giant Liposomes
Giant proteoliposomes were added to a precoated glass slide of β-casein (30 min
incubation of 0.5 mg/mL) for coreTAPLmVenus containing proteoliposomes or to a
biotinylated-PEG/PEG-functionalized glass slide (preincubated with streptavidin 0.2 mg/mL
for 30 min) for TmrAB proteoliposomes. After streptavidin removal, biotinylated proteoGUVs
were sedimented for 10 min before washing and addition of transport buffer (20 mM
HEPES/NaOH pH 7.5, 150 mM NaCl, 1 mM MgCl2, 200 mM glucose, 2 mM
phosphocreatine, 0.3 g/L phosphocreatine kinase, 0.2–3 μM C4F) at 40 °C.
The transport of TmrAB was started by addition of 2 mM ATP, and substrate translocation
was observed for around 2 h via confocal laser scanning microscopy (CLSM,
Zeiss LSM 880, λex/C4F = 488 nm,
λex/Oyster647/ATTO655/Alexa647 = 633 nm, λex/ATTO390 =
405 nm). Due to the short lifetime of TAPL at 37 °C, proteoliposomes were directly
added in transport buffer containing 2 mM ATP, 3 μM C4F, 1 mM MgCl2, 2 mM
phosphocreatine, and 0.3 g/L phosphocreatine kinase and subsequently imaged for 1–3
h. The fluorescein-labeled peptide C4F was used because it is considered a high-affinity
substrate with well-described transport characteristics.[9,11,54]
Light-Triggered Peptide Export in Giant Liposomes
The export buffer (20 mM HEPES/NaOH pH 7.5, 150 mM NaCl, 1 mM MgCl2, 200 mM
sucrose, 2 mM phosphocreatine, 0.1 g/L phosphocreatine kinase, 10–20 μM C4F,
2 mM DMNPE-caged ATP, Thermo Fischer Scientific) was encapsulated in giant proteoliposomes
(TmrAB), and subsequently applied to a biotinylated-PEG/PEG-functionalized glass slide
(preincubated with streptavidin 0.2 mg/mL for 30 min). The photocleavable ATP for
individual liposomes was in situ activated by illumination of 405 nm for
∼30 s with 99% laser intensity (∼4.5 mW μm–2),
followed by imaging via CLSM for 1–3 h.
Light-Triggered Peptide Export in Giant Liposomes Followed by ATP-Triggered Peptide
Import
The export buffer (20 mM HEPES/NaOH pH 7.5, 150 mM NaCl, 1 mM MgCl2, 200 mM
sucrose, 2 mM phosphocreatine, 0.1 g/L phosphocreatine kinase, 10–20 μM C4F,
2 mM DMNPE-caged ATP) was encapsulated in giant proteoliposomes (TmrAB), and subsequently
applied to a biotinylated-PEG/PEG-functionalized glass slide (preincubated with
streptavidin 0.2 mg/mL for 30 min). The photocleavable ATP for individual liposomes was
in situ activated by illumination of 405 nm for ∼30 s with 99%
laser intensity (∼4.5 mW μm–2), followed by imaging for
1–3 h via CLSM. Import processes were triggered by the addition of
2 mM ATP, and an ARS (0.3 g/L phosphocreatine kinase and 2 mM phosphocreatine), import was
followed for 1–3 h by CLSM. More images of the export/import assay shown in Figure e are given in Figure S10.
Analysis of Import and Export Processes
Giant liposomes with minimal Oyster647 leakage were analyzed. The mean gray
values of the fluorescent traces (import experiments) were extracted and processed by the
open-source imaging analysis software ImageJ.[55] Accumulations were
extracted for each time point in each time trace (exemplary; an accumulation of two
reflects a fluorescence intensity twice the background of the GUV exterior). The C4F
concentration in the liposome was determined by calibrating the accumulation with the C4F
concentration in the exterior. Subsequently, the number of C4F molecules was quantified by
using the vesicle volume. The number of TmrAB (Mw =
134 900 Da) molecules per liposome was calculated for the total surface area (inner
and outer leaflet surfaces were calculated independently with a membrane thickness of 5
nm), with the protein-to-lipid ratio of 1:15w/w, and with the lipid areas of
63.5, 61.0, and 62.8 Å2 for POPC, POPE, and POPG, respectively, in
relation to the molar lipid ratios.[56] Thereby, the number of C4F
peptides transported per TmrAB per minute for individual liposome was calculated. The
resulting saturation curves were fitted linearly to extract initial rate constants, which
were plotted versus peptide concentrations. The mean and median values
were calculated, with the latter being applied because of its lower dependence on
outliers.The mean gray values for export processes were analyzed by ImageJ (see above), including
background correction. The resulting traces were fitted monoexponentially with the
following
equation:Namely the export constant (k), the initial
concentration (A), and an additional correction constant
(y0). Subsequently, the resulting export rate constants were
analyzed by descriptive statistics and summarized in a histogram (OriginPro 2020).
Liposome Geometry Calculations
The volume and surface area of giant and large liposomes were determined by assuming an
ideal sphere. The membrane thickness was assumed to be 5 nm, and the inner and outer
leaflet surface areas were calculated independently. The number of lipids per vesicle was
quantified by dividing the total surface area by the average surface area of the used
lipids including molar ratios. For POPC, POPE, and POPG, respectively, an lipid area of
63.5, 61.0, and 62.8 Å2 was taken into account.[56] With
the ratio of TmrAB (Mw = 134 900 Da) reconstituted per
liposome of 1:15w/w, the number of TmrAB in a single liposome was derived. For
large unilamellar vesicles, a protein-to-lipid ratio of 1:20w/w was
used.[11] A 50:50 orientation for ABC transporters was assumed for the
calculations. All values in the table reflect mean values for the given number of GUVs
(unless otherwise stated).
Calculation for the Export Experiments
As indicated in the analysis section, export traces were fitted monoexponentially, and
the extracted efflux constants in 1/min were used to compute the number of substrate
molecules per TmrAB per minute with the encapsulated substrate concentration and the
liposome geometries. As described before, a membrane thickness of 5 nm was assumed for the
surface area calculation of the inner and outer leaflet.
Data Presentation and Statistics
All measurements were performed at least in triplicates (n ≥ 3).
In all column and XY diagrams, mean values ± SD were presented. Diagrams were
prepared in OriginPro 2020 and further processed with Adobe Illustrator.
Authors: Tina Zollmann; Gemma Moiset; Franz Tumulka; Robert Tampé; Bert Poolman; Rupert Abele Journal: Proc Natl Acad Sci U S A Date: 2015-02-02 Impact factor: 11.205
Authors: Anne Nöll; Christoph Thomas; Valentina Herbring; Tina Zollmann; Katja Barth; Ahmad Reza Mehdipour; Thomas M Tomasiak; Stefan Brüchert; Benesh Joseph; Rupert Abele; Vincent Oliéric; Meitian Wang; Kay Diederichs; Gerhard Hummer; Robert M Stroud; Klaas M Pos; Robert Tampé Journal: Proc Natl Acad Sci U S A Date: 2017-01-09 Impact factor: 11.205
Authors: Andreas Weinberger; Feng-Ching Tsai; Gijsje H Koenderink; Thais F Schmidt; Rosângela Itri; Wolfgang Meier; Tatiana Schmatko; André Schröder; Carlos Marques Journal: Biophys J Date: 2013-07-02 Impact factor: 4.033
Authors: Mark K Doeven; Joost H A Folgering; Victor Krasnikov; Eric R Geertsma; Geert van den Bogaart; Bert Poolman Journal: Biophys J Date: 2004-12-01 Impact factor: 4.033